Knott David M Jr
- SEC CIK
- 0001892770
- Latest filing
- Aug 12, 2026
BBIO holding history
BridgeBio Pharma, Inc. in every 13F filed by Knott David M Jr, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BBIO overviewAll 13F holders of BBIOFull Q2 2026 holdings
- Shares (Q2 2026)
- 92,850
- Value
- $6.92M
- % of portfolio
- 3.7%
- Quarters held
- 12
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 92,850 | $6.92M | 3.7% | +2,850+3.2% | Added | Holders |
| Q1 2026 | 90,000 | $6.68M | 4.0% | +5,000+5.9% | Added | Holders |
| Q4 2025 | 85,000 | $6.50M | 3.0% | 00.0% | Unchanged | Holders |
| Q3 2025 | 85,000 | $4.41M | 1.8% | +5,000+6.3% | Added | Holders |
| Q2 2025 | 80,000 | $3.45M | 1.6% | +80,000 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −21,000−100.0% | Sold out | Holders |
| Q2 2024 | 21,000 | $532.0K | 0.2% | +5,000+31.3% | Added | Holders |
| Q1 2024 | 16,000 | $495.0K | 0.2% | +4,000+33.3% | Added | Holders |
| Q4 2023 | 12,000 | $484.0K | 0.2% | +3,000+33.3% | Added | Holders |
| Q3 2023 | 9,000 | $237.0K | 0.1% | +9,000 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −143,096−100.0% | Sold out | Holders |
| Q3 2022 | 143,096 | $1.42M | 0.7% | −70,110−32.9% | Reduced | Holders |
| Q2 2022 | 213,206 | $1.94M | 0.9% | +12,313+6.1% | Added | Holders |
| Q1 2022 | 200,893 | $2.04M | 0.7% | +200,893 | New | Holders |